Skip to main content
Have a personal or library account? Click to login
Development and evaluation of in situ novel intragastric controlled-release formulation of hydrochlorothiazide Cover

Development and evaluation of in situ novel intragastric controlled-release formulation of hydrochlorothiazide

Open Access
|Mar 2011

References

  1. M. Kuentz and D. Rothlisberger, Determination of the optimal amount of water in liquidfill masses for hard gelatin capsules by means of texture analysis and experimental design,(2002) 145-152; DOI: 10.1016/S0378-5173(02)00022-4.
  2. P. Kozlov and G. Burdygina, The structure and properties of solid gelatin and the principles of their modification,(1983) 651-666; DOI: 10.1016/0032-3861(83)90001-0.
  3. E. T. Cole, D. Cade and H. Benameur, Challenges and opportunities in the encapsulation of liquid and semi-solid formulations into capsules for oral administration,(2008) 747-756; DOI: 10.1016/j.addr.2007.09.009.
  4. G. Reich, Effect of sorbitol specification on structure and properties of soft gelatin capsules,(1996) 941-946.
  5. S. Nagata, Advantages to HPMC capsules: A new generation's hard capsule,(2002) 6-9.
  6. S. K. Dordunoo, J. L. Ford and M. H. Rubinstein. Preformulation studies on solid dispersions containing triamterene or temazepam in polyethylene glycols or gelucire 44/14 for liquid filling of hard gelatin capsules,(1991) 1685-1713; DOI: 10.3109/03639049109057315.
  7. W. J. Bowtle and N. J. Barker, A new approach to vancomycin formulation using filling technology for semisolid matrix capsules,(1988) 86-97.
  8. , USP Convention, Rockville (MD), Asian Edition, 2005.
  9. K. A. Shah, J. W. Warren, G. Onwuelezi, J. S. Benmaman and C. M. Monk, In vitro release of hydrochlorothiazide from capsule formulations,(1981) 683-691; DOI: 10.3109/03639048109055692.
  10. P. R. Petrovick, M. Jacob, D. Gaudy, V. Bassani and S. Guterres, Influence of adjuvants on the in vitro dissolution of hydrochlorothiazide from hard gelatin capsules,(1991) 49-53; DOI: 10.1016/0378-5173(91)90342-L.
  11. S. Miyazaki, N. Kawasaki, W. Kubo, K. Endo and D. Attwood, Comparison of in situ gelling formulations for the oral delivery of cimetidine,(2001) 161-168; DOI: 10.1016/S0378-5173(01)00669-X.
  12. V. Shah, Y. Tsong, P. Sathe and J. Liu, In vitro dissolution profile comparison-statistics and analysis of the similarity factor f2,(1998) 889-896; DOI: 10.1023/A:1011976615750.
  13. U. S. Department of Health and Human Services, Food and Drug Administration Center for Drug Evaluation and Research,, FDA CDER, Rockwille (MD) 1997;
  14. N. Gatchalian, L. Joseph, C. Westergom and N. Langley, Purity of PEG 400 effects the stability of gelatin capsules, American Accociation of Pharmaceutical Scientists Annual Meeting, November 6-10, 2005, Book of Abstracts, AAPS, Nashville (TN) 2005, R6012.
DOI: https://doi.org/10.2478/v10007-011-003-9 | Journal eISSN: 1846-9558 | Journal ISSN: 1330-0075
Language: English, Croatian
Page range: 73 - 82
Published on: Mar 15, 2011
Published by: Croatian Pharmaceutical Society
In partnership with: Paradigm Publishing Services
Related subjects:

© 2011 Ravikumar Patel, Jayvadan Patel, published by Croatian Pharmaceutical Society
This work is licensed under the Creative Commons License.